Lipid and pleiotropic effects of atorvastatin in patients with acute coronary syndrome
Aim. To study the effects of an HMG-CoA reductase inhibitor atorvastatin in patients with acute coronary syndrome (ACS).Material and methods. The study included 116 ACS patients, divided into two comparable groups. Total follow-up time was 180±7 days.Results. In 6 months of the follow-up, the patien...
Saved in:
| Main Authors: | A. A. Yalymov, G G Shekhyan, A. A. Bylyeva, V. S. Zadionchenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1609 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endotelioand cardioprotective effects of HMG-Co-A reductase in endotoksininducing endotelial dysfunction
by: T. A. Denisuk, et al.
Published: (2015-10-01) -
Diabetogenic effect of statins: a comprehensive review on the clinical relevance, underlying pathomechanisms and rationale for tailored statin therapy
by: Małgorzata Ostrowska, et al.
Published: (2015-12-01) -
Lipid and pleiotropic effects of atorvastatin in patients with high cardiovascular risk
by: R. S. Karpov, et al.
Published: (2009-08-01) -
Microbial Test-System for Screening of Inhibitors of Sterol Biosynthesis
by: A. S. Trenin
Published: (2020-05-01) -
EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE
by: G. A. Batrak, et al.
Published: (2015-09-01)